Associations and interactions between lipid profiles, retinopathy and nephropathy in patients with type 1 diabetes: the FinnDiane Study

HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes

(2013) K. Hietala et al.   DIABETOLOGIA

Non-invited Review: Prevention of microvascular diabetic complications by fenofibrate: lessons from FIELD and ACCORD

(2011) Michel P Hermans   Diabetes & Vascular Disease Research

Serum Apolipoprotein AI and B Are Stronger Biomarkers of Diabetic Retinopathy Than Traditional Lipids

(2011) M. B. Sasongko et al.   DIABETES CARE

Lipids and diabetic retinopathy

(2011) Laurence S Lim et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies

(2011) A D Wright et al.   EYE

Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

(2008) Nish Chaturvedi et al.   LANCET

The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII

(2008) Ronald Klein et al.   OPHTHALMOLOGY